SHANGHAI BIO-HEART BIOLOGICAL TECHNSHANGHAI BIO-HEART BIOLOGICAL TECHNSHANGHAI BIO-HEART BIOLOGICAL TECHN

SHANGHAI BIO-HEART BIOLOGICAL TECHN

No trades
See on Supercharts

2185 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the research and development of interventional cardiovascular device therapies. It focuses on bioresorbable scaffold therapy addressing the unmet medical needs of Chinese patients for the treatment of coronary or peripheral artery diseases and renal denervation therapy addressing the unmet medical needs of patients for the treatment of uncontrolled hypertension and resistant hypertension. The company was founded by Li Wang and Guo Hui Wang on July 18, 2014 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
2185 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company